Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Transplantation. 2022 Jan 1;106(1):72–84. doi: 10.1097/TP.0000000000003615

Table 3:

Unadjusted and adjusted cox hazard model for hazard of pre-transplant death, by early/late evaluation (use 30 days as cutoff)

Univariable Multivariable

Parameter Value HR (95%CI) P aHR (95%CI) P

Time from referral to evaluation Late Evaluation REF REF
Early Evaluation 0.74 (0.58,0.94) 0.0125 0.70 (0.54,0.91) 0.0070

Age Age at Referral 1.02 (1.00,1.04) 0.0403 1.03 (1.01,1.05) 0.0025

Center Station 1 REF REF
Station 2 0.59 (0.36,0.98) 0.0420 0.56 (0.33,0.97) 0.0371
Station 3 0.68 (0.46,1.01) 0.0565 0.64 (0.42,0.99) 0.0456
Station 4 1.22 (0.87,1.70) 0.2493 1.03 (0.72,1.47) 0.8849
Station 5 0.70 (0.46,1.08) 0.1103 0.64 (0.40,1.02) 0.0595
Station 6 0.79 (0.53,1.20) 0.2757 0.84 (0.53,1.32) 0.4441

Etiology NAFLD REF REF
Autoimmune hepatitis 0.67 (0.16,2.76) 0.5751 0.63 (0.12,3.27) 0.5842
Cryptogenic Cirrhosis 1.33 (0.32,5.50) 0.6985 1.75 (0.32,9.66) 0.5193
Alcohol 0.70 (0.47,1.05) 0.0859 0.58 (0.37,0.90) 0.0146
HBV 0.59 (0.23,1.51) 0.2714 0.63 (0.24,1.65) 0.3461
HCV 0.69 (0.45,1.06) 0.0865 0.63 (0.38,1.02) 0.0614
HCV + Alcohol 0.81 (0.56,1.17) 0.2534 0.80 (0.51,1.26) 0.3342
HFE 0.50 (0.16,1.63) 0.2524 0.67 (0.20,2.31) 0.5289
PBC 0.83 (0.40,1.72) 0.6123 0.84 (0.41,1.70) 0.6200
PSC 2.00 (0.84,4.75) 0.1154 1.55 (0.74,3.23) 0.2414

Gender Male REF REF
Female 1.52 (0.83,2.78) 0.1731 1.78 (0.95,3.31) 0.0712

Race/Ethnicity White REF REF
Black 0.83 (0.59,1.17) 0.2808 0.75 (0.52,1.08) 0.1173
Other 2.08 (1.39,3.11) 0.0004 2.46 (1.60,3.77) <.0001
Hispanic / Latino 0.97 (0.65,1.44) 0.8674 1.07 (0.67,1.70) 0.7905
Unknown 0.66 (0.36,1.21) 0.1753 0.64 (0.33,1.25) 0.1903

BMI at referral Normal Weight REF REF
Underweight 1.27 (0.61,2.67) 0.5257 1.49 (0.72,3.11) 0.2862
Overweight 0.86 (0.62,1.19) 0.3573 1.01 (0.72,1.42) 0.9522
Obese 1.00 (0.73,1.37) 0.9870 1.18 (0.84,1.66) 0.3463

Diabetes at referral No REF REF
Yes 0.71 (0.56,0.89) 0.0029 0.67 (0.53,0.86) 0.0013

Tobacco Use at Diagnosis of Cirrhosis Never smoker REF REF
Current smoker 1.20 (0.91,1.57) 0.2059 1.11 (0.80,1.53) 0.5432
Former smoker 1.29 (0.95,1.75) 0.1007 1.22 (0.89,1.66) 0.2193
Unknown 1.49 (0.54,4.05) 0.4398 1.83 (0.72,4.67) 0.2035

AUDIT-C Score at referral Low REF REF
High 1.10 (0.78,1.54) 0.5928 1.17 (0.8,1.71) 0.4153

HCV viremia at referral No REF REF
Yes 1.03 (0.8,1.33) 0.8107 1.04 (0.76,1.41) 0.8172

Cirrhosis comorbidity index at referral 0 REF REF
1+0 1.14 (0.86,1.50) 0.3564 1.26 (0.92,1.73) 0.1486
1+1 1.28 (0.79,2.08) 0.3116 1.39 (0.80,2.42) 0.2363
3+0 1.49 (0.85,2.61) 0.1638 1.18 (0.62,2.23) 0.6129
3+1 1.55 (0.84,2.85) 0.1580 1.53 (0.85,2.75) 0.1552

CAD at referral No REF REF
Yes 1.11 (0.86,1.45) 0.4221 1.14 (0.87,1.50) 0.3340

Liver cancer at referral No REF REF
Yes 0.82 (0.65,1.03) 0.0842 0.68 (0.22,0.94) <.0001

Disease within Milan criteria at referral No REF REF
Yes 0.57 (0.34,0.94) 0.0279 0.13 (0.05,0.31) <.0001

Down-staging of HCC No REF REF
Yes 0.30 (0.12,0.78) 0.0130 0.27 (0.10,0.77) 0.0142

Tumor progression while waiting No REF REF
Yes 2.59 (1.83,3.67) <.0001 2.69 (1.88,3.84) <.0001

BCLC staging at listing 0 REF REF
A 2.49 (1.26,4.92) 0.0085 2.70 (1.37,5.33) 0.0041
B 1.27 (0.51,3.21) 0.6083 0.68 (0.23,1.99) 0.4814

Distance (in miles) Distance from referring VA to transplant center in miles 0.99 (0.99,1.01) 0.3970 0.99 (0.99,1.01) 0.8634

MELD at referral MELD Score at Referral 1.03 (1.01,1.04) <.0001 1.04 (1.02,1.06) <.0001